MRIC News Alert Mri Interventions (MRIC) 0.7900 12/16/2014 2

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mri Interventions (MRIC) 0.7900 $MRIC

MRI Interventions Welcomes Seasoned Medical Device Executive Wendelin Maners as Its New Vice President, Marketing
GlobeNewswire - Thu Dec 04, 7:33AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announces the addition of medical device veteran Wendelin Maners in the role of Vice President, Marketing, as CEO-elect Frank Grillo solidifies his management team. As Vice President, Marketing, Ms. Maners will head all marketing activities and programs, as well as develop and lead internal and external training programs for the Company.
BSX: 12.95 (+0.15), CYBX: 54.26 (+0.36)

MRI Interventions' (MRIC) CEO Kimble Jenkins on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 13, 6:23PM CST


MRI Interventions Announces Third Quarter 2014 Financial Results
GlobeNewswire - Thu Nov 13, 3:00PM CST
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today its financial results for the quarter ended September 30, 2014.

MRI Interventions to Report Third Quarter 2014 Financial Results
GlobeNewswire - Thu Nov 06, 4:16PM CST
MRI Interventions, Inc. (OTCQB: MRIC) announced today that it will release its third quarter 2014 financial results on Thursday, November 13, 2014, after the close of the U.S. financial markets. MRI Interventions will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the company's results.

MRI Interventions Announces Participation in Fall Medical Conferences
GlobeNewswire - Wed Oct 08, 7:35AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced its participation as an exhibitor at two major medical conferences this Fall.

MRI Interventions Provides Perspective on Third Quarter, as Frank Grillo Assumes Leadership
GlobeNewswire - Mon Oct 06, 7:30AM CDT
MRI Interventions, Inc. (OTCQB:MRIC), maker of the innovative ClearPointneuro navigation system, today welcomed Frank Grillo as its new President and CEO-elect and provided commentary on its third quarter 2014 results.

MRI Interventions Announces Frank Grillo, Intuitive Surgical Executive, to Become CEO and Kimble Jenkins to Become Executive Chairman
GlobeNewswire - Thu Sep 11, 8:48AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that medical device veteran Frank Grillo will become the company's new Chief Executive Officer. Grillo will join MRI Interventions as President on October 6, 2014 and will become CEO on January 1, 2015. Kimble Jenkins, who has led MRI Interventions since 2003, will assume the position of Executive Chairman on January 1, 2015 and will continue to be actively involved with the company.
ISRG: 497.17 (-1.84)

MRI Interventions Welcomes Pascal E.R. Girin to Board of Directors
GlobeNewswire - Wed Sep 03, 7:30AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that industry veteran Pascal E.R. Girin has joined its Board of Directors. Mr. Girin possesses over two decades of management and executive experience in the field of medical technology with a proven track record of high performance in publicly traded and private equity-backed companies.

UC San Diego Health System Utilizes Platform Capabilities of MRI Interventions' ClearPoint System to Conduct Three Back-to-Back Procedures on a Single Patient
GlobeNewswire - Tue Aug 19, 7:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that neurosurgeons at UC San Diego Health System have utilized the ClearPoint system's platform capabilities to facilitate three same-setting MRI-guided neurosurgical procedures for a single patient. The team, led by Clark C. Chen, MD, PhD, vice-chairman of Academic Affairs for the Division of Neurosurgery at UC San Diego School of Medicine, biopsied a patient's brain tumor, aspirated a fluid-filled section of the tumor, and ablated the tumor, all under real-time MRI guidance enabled by the ClearPoint system in the hospital's diagnostic MRI suite.

MRI Interventions Announces Second Quarter 2014 Financial Results
GlobeNewswire - Thu Aug 07, 3:00PM CDT
-- Reports record total product revenues for the quarter

MRI Interventions to Report Second Quarter 2014 Financial Results
GlobeNewswire - Wed Jul 30, 7:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) announced today that it will release its second quarter 2014 financial results on Thursday, August 7, 2014, after the close of the U.S. financial markets. MRI Interventions will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the company's results.

Collaborations in Neurosurgery: MRI Interventions' ClearPoint System and Monteris Medical's NeuroBlate System Utilized Jointly to Enable Laser Ablation of Brain Tumor
GlobeNewswire - Mon Jun 23, 7:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) and Monteris Medical, Corp. jointly announced the utilization of their respective product platforms, the ClearPoint Neuro Intervention System and the NeuroBlate System, at UC San Diego Health System to enable minimally invasive (MR-guided) laser treatment in a patient afflicted with glioblastoma, a type of brain tumor. In a procedure led by Dr. Clark Chen, MD, PhD, Chief of Stereotactic and Radiosurgery and Vice-Chairman of Academic Affairs, MRI Interventions' ClearPoint System was used to establish the path to the tumor while Monteris' NeuroBlate System was used to ablate (heat) tumor cells. The entire procedure was performed within a diagnostic MRI suite at UC San Diego Health System.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Biohaven's BHV-1530 Data Earns a Careful Investor Look

Updated Category News Views 19

Thirty heavily treated cancer patients can make a molecule look brilliant or merely lucky, and BHV-1530 is still living in that uncomfortable early-stage gap. Biohaven presented Phase 1 results at ENA 2026 that deserve real attention, particularly because the responses showed up in patients with few attractive remaining options. But this is not the moment to confuse a...

Continue Reading
Yunnan Tin’s AI Materials Push Has Real Operating Teeth

Updated Category News Views 66

Tin rarely gets the spotlight until the machinery behind modern computing starts demanding more of it. Yunnan Tin Group is making the sensible case that this unglamorous metal can matter a great deal in semiconductors, artificial intelligence infrastructure and new-energy hardware. There is plenty of corporate ambition wrapped around that case, naturally, but a few...

Continue Reading
Yiwu Squishies Turn Viral Demand Into Factory Backlogs Worldwide

Updated Category News Views 21

A pizza-shaped stress toy booking more than one million units is the sort of detail that makes a jaded market watcher sit up before rolling his eyes at the word “viral.” Yiwu’s squishy-toy surge appears to have moved beyond a few social-media impulses and into actual factory scheduling, repeat purchase orders and supermarket procurement. That is meaningful. It is...

Continue Reading
Tongwei's 846 MW Romania Deal Tests Solar Supply Scale

Updated Category News Views 74

Eight hundred forty-six megawatts of panels do not quietly roll out the factory gate. Tongwei’s supply agreement with Rezolv Energy for Romania’s Dama Solar project is a hefty piece of utility-scale solar business, and the first truckload has already left Tongwei’s Nantong facility. That matters more than another polished signing-ceremony photo: equipment is moving,...

Continue Reading
NVE Revenue Pull-Forward Raises Hard Investor Questions

Updated Category News Views 50

A Quarter Can Look Great Until It Doesn’t NVE investors got a nasty lesson in revenue timing, the sort that makes even old hands check the fine print twice. On July 22, 2026, the company reported sequential revenue growth of 43% and net-income growth of 23%. The next trading day, shares vaulted $47.53, or 54%. Then came October, and the floor gave way: NVE reported that...

Continue Reading
Goosehead Restatement Puts Accounting Trust on Trial

Updated Category News Views 87

A filing delay can be irritating; a multi-year no-rely warning is something uglier. Goosehead Insurance told investors on November 9, 2026, that it would not timely file its quarterly report for the period ended September 30 and that prior financial statements must be restated. That is not a garden-variety paperwork hiccup. It reaches back across fiscal 2023, 2024 and...

Continue Reading
Brightstar Picks Warsop for Its Next CEO Chapter Ahead

Updated Category News Views 31

A Handoff With Plenty Riding on the Rails A lottery supplier changing captains is not usually fireworks, but this one deserves a hard look. Brightstar Lottery has named Thomas Warsop to replace Vince Sadusky as chief executive officer and board member effective January 1, 2027. Sadusky is retiring from both posts on that date. The company is telegraphing an orderly baton...

Continue Reading
T. Rowe Price Expands Teams Across 12 Fund Strategies

Updated Category News Views 49

A Quiet Personnel Shift With Real Stakes Twelve strategy changes may sound like administrative wallpaper, but asset managers live and die by who makes the calls. T. Rowe Price is broadening portfolio-management teams across equity and fixed-income offerings while insisting that each strategy's philosophy, process, and risk limits remain intact. Fine. That is the stated...

Continue Reading
Abbe Lane Estate Puts Jewelry Demand on Full Display

Updated Category News Views 101

Glamour Is Walking Back Into the Auction Room Abbe Lane’s jewelry is not being offered as a vague nostalgia exercise; it is arriving with dates, a setting, and a clear split between two December sales. John Moran Auctioneers will lead with The Estate of Abbe Lane on Wednesday, December 9, 2026, at 10:00 a.m. PST, then follow with its Jewelry & Watches auction on...

Continue Reading
First US Extends Buyback Clock Through Year-End 2027

Updated Category News Views 217

A buyback extension is not a thunderclap; it is a bank board keeping a useful tool within reach. First US Bancshares has pushed the expiration of its existing repurchase authorization from December 31, 2026, to December 31, 2027. That matters, but investors ought to resist turning a calendar change into a grand earnings prophecy. The company has bought back 2,122,972...

Continue Reading

Top 5 Most Recently Viewed Articles

Navigating Component Obsolescence: Key Trends and Insights

Updated Category News Views 170

Understanding Component Obsolescence in Today's Market In the rapidly evolving world of semiconductors and electronic components, tracking obsolescence has become crucial. Bill Bradford, President of Flip Electronics, sheds light on these trends that are shaping the industry as we move towards 2026. The market has seen a significant shift, primarily due to increasing...

Continue Reading
Exploring Class Action Claims Against iLearningEngines - AILE

Updated Category News Views 181

Understanding the Class Action Lawsuit Against iLearningEngines Faruqi & Faruqi, LLP, a prominent name in securities litigation, is taking steps to inform investors about a significant class action lawsuit related to iLearningEngines, Inc. The law firm, known for its commitment to protecting investors' rights, has set a deadline for potential lead plaintiffs in this case....

Continue Reading
Key Stock Movements: Sanmina and other Performers Soar

Updated Category News Views 440

Key Stock Movements on Tuesday U.S. stocks exhibited mixed performance with the Dow Jones index declining around 100 points. Despite the overall market volatility, several companies reported substantial improvements in their stock values on Tuesday. Sanmina Corporation Performance Sanmina Corporation (NASDAQ: SANM) saw an impressive rise in its stock during Tuesday's...

Continue Reading
Segal Trials' Innovations in Schizophrenia Treatment with LB-102

Updated Category News Views 303

Segal Trials Advances Schizophrenia Research with LB-102 Segal Trials is making significant strides in the field of schizophrenia research, focusing on the innovative treatment method involving LB-102. This investigational drug, which is a potential first-in-class benzamide antipsychotic, is being evaluated in a Phase 2 trial. The main goal of this study is to assess the...

Continue Reading
Innovative Vehicle Safety System Promises Improved Driver Focus

Updated Category News Views 237

Introduction to an Innovative Safety Solution In today's fast-paced world, driving distractions can have serious consequences. An inventive mind has created a new device called SAFE DRIVE, aimed at enhancing driver concentration and reducing the risks associated with smartphone usage while driving. Concept Behind SAFE DRIVE The SAFE DRIVE invention is designed with a...

Continue Reading